{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:57:27Z","timestamp":1793307447378,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014807","name":"Cancer Research Coordinating Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008637","name":"National Cancer Institute Center for Strategic Scientific Initiatives","doi-asserted-by":"publisher","award":["1DP2CA247830-01"],"award-info":[{"award-number":["1DP2CA247830-01"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015402","name":"Canada Research Coordinating Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.immuni.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T10:43:31Z","timestamp":1749120211000},"page":"2002-2018.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy"],"prefix":"10.1016","volume":"58","author":[{"given":"Jesse","family":"Garcia Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Gonzalez Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ybarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Flores Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Portnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1479-9840","authenticated-orcid":false,"given":"Michel","family":"DuPage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2025.05.001_bib1","first-page":"154","article-title":"The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas","volume":"26","author":"McCarthy","year":"2006","journal-title":"Iowa Orthop. J."},{"key":"10.1016\/j.immuni.2025.05.001_bib2","first-page":"1","volume":"276","author":"Nauts","year":"1953","journal-title":"Acta Med. Scand. Suppl."},{"key":"10.1016\/j.immuni.2025.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/postgradmedj\/79.938.672","article-title":"Dr William Coley and tumour regression: a place in history or in the future","volume":"79","author":"Hoption Cann","year":"2003","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.immuni.2025.05.001_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133073","article-title":"BCG in Bladder Cancer Immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.immuni.2025.05.001_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt937","article-title":"Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins","volume":"22","author":"Yu","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2025.05.001_bib6","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.7150\/thno.42121","article-title":"Imaging of tumor colonization by Escherichia coli using 18F-FDS PET","volume":"10","author":"Kang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.immuni.2025.05.001_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","article-title":"Microbiome analyses of blood and tissues suggest cancer diagnostic approach","volume":"579","author":"Poore","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.05.001_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2025.05.001_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal Microbiota Promote Lung Cancer Development via \u03b3\u03b4 T Cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib12","first-page":"4537","article-title":"Tumor-targeted Salmonella as a novel anticancer vector","volume":"57","author":"Pawelek","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib13","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.05.001_bib15","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","article-title":"A pan-cancer analysis of the microbiome in metastatic cancer","volume":"187","author":"Battaglia","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.cell.2023.03.012","article-title":"The intratumoral microbiota: From microniches to single cells","volume":"186","author":"Bullman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib17","article-title":"Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrmicro.2017.172","article-title":"Engineering bacteria for diagnostic and therapeutic applications","volume":"16","author":"Riglar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2025.05.001_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.05.001_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.05.001_bib22","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1073\/pnas.1801910115","article-title":"Recombinant Listeria promotes tumor rejection by CD8+ T cell-dependent remodeling of the tumor microenvironment","volume":"115","author":"Deng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjc.6604526","article-title":"Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases","volume":"99","author":"Kim","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.micinf.2007.05.010","article-title":"Listeria as a vaccine vector","volume":"9","author":"Bruhn","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.immuni.2025.05.001_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1278011","article-title":"Listeria monocytogenes: a promising vector for tumor immunotherapy","volume":"14","author":"Ding","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nm0595-471","article-title":"A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours","volume":"1","author":"Pan","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.05.001_bib28","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1158\/1078-0432.CCR-19-0070","article-title":"Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma","volume":"25","author":"Hassan","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1200\/JCO.2014.57.4244","article-title":"Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer","volume":"33","author":"Le","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.immuni.2025.05.001_bib30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2020.06.493","article-title":"Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology\/gynecologic oncology group study","volume":"158","author":"Huh","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.immuni.2025.05.001_bib31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/IGC.0000000000001235","article-title":"A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer","volume":"28","author":"Basu","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41391-021-00402-8","article-title":"Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer","volume":"25","author":"Drake","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.immuni.2025.05.001_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/oncolo\/oyac048","article-title":"ADXS31142 Immunotherapy \u00b1 Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I\/II KEYNOTE-046 Study","volume":"27","author":"Stein","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.immuni.2025.05.001_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imm.13058","article-title":"Treg programming and therapeutic reprogramming in cancer","volume":"157","author":"M.A. Moreno Ayala","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.immuni.2025.05.001_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib36","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.immuni.2025.05.001_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1084\/jem.20171435","article-title":"Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity","volume":"215","author":"Perry","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: Immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/2326-6066.CIR-15-0230","article-title":"Reduction of MDSCs with all-trans retinoic acid improves CAR therapy efficacy for sarcomas","volume":"4","author":"Long","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00784-1","article-title":"Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.05.001_bib43","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.immuni.2023.07.018","article-title":"Targeting innate immune pathways for cancer immunotherapy","volume":"56","author":"Cao","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.05.001_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.seminoncol.2019.10.004","article-title":"Coley\u2019s immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity","volume":"46","author":"Uher","year":"2019","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.immuni.2025.05.001_bib45","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/1078-0432.CCR-13-2116","article-title":"Intratumoral immunization: a new paradigm for cancer therapy","volume":"20","author":"Marabelle","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib46","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2159-8290.CD-18-0743","article-title":"In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma","volume":"8","author":"Frank","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2025.05.001_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz2738","article-title":"NK cells mediate clearance of CD8+ T cell-resistant tumors in response to STING agonists","volume":"5","author":"Nicolai","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib48","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/s41388-019-1072-3","article-title":"Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization","volume":"39","author":"Xu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2025.05.001_bib49","first-page":"E8698","article-title":"Adjuvant effect of the novel TLR1\/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib50","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2025.05.001_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642316","article-title":"Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies","volume":"12","author":"Oladejo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib52","doi-asserted-by":"crossref","first-page":"13832","DOI":"10.1073\/pnas.0406035101","article-title":"Listeria-based cancer vaccines that segregate immunogenicity from toxicity","volume":"101","author":"Brockstedt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib107","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-14-2645","article-title":"Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling","volume":"75","author":"Roy","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib53","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-20-0133","article-title":"Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes","volume":"10","author":"Miyabayashi","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2025.05.001_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001326","article-title":"Dynamic imaging of the effector immune response to listeria infection in vivo","volume":"7","author":"Waite","year":"2011","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.immuni.2025.05.001_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/IAI.67.1.131-139.1999","article-title":"Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes","volume":"67","author":"Moors","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2025.05.001_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jlb.35.2.193","article-title":"Killing of Listeria monocytogenes by Inflammatory Neutrophils and Mononuclear Phagocytes From Immune and Nonimmune Mice","volume":"35","author":"Czuprynski","year":"1984","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.immuni.2025.05.001_bib57","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4049\/jimmunol.1600599","article-title":"The Essential Role of Neutrophils during Infection with the Intracellular Bacterial Pathogen Listeria monocytogenes","volume":"197","author":"Witter","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib58","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4049\/immunohorizons.1900065","article-title":"Neutrophils Are More Effective than Monocytes at Phagosomal Containment and Killing of Listeria monocytogenes","volume":"3","author":"Okunnu","year":"2019","journal-title":"Immunohorizons"},{"key":"10.1016\/j.immuni.2025.05.001_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","article-title":"Neutrophils as active regulators of the immune system in the tumor microenvironment","volume":"102","author":"Shaul","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.immuni.2025.05.001_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the Tumor Microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45957","article-title":"Cas9+ conditionally-immortalized macrophages as a tool for bacterial pathogenesis and beyond","volume":"8","author":"Roberts","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2025.05.001_bib62","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201803","article-title":"Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice","volume":"218","author":"Veglia","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-1060-2_10","article-title":"In Vitro Generation of Murine Myeloid-Derived Suppressor Cells, Analysis of Markers, Developmental Commitment, and Function","volume":"2236","author":"Eckert","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2025.05.001_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13175","article-title":"Why is Listeria monocytogenes such a potent inducer of CD8+ T-cells?","volume":"22","author":"Ch\u00e1vez-Arroyo","year":"2020","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.immuni.2025.05.001_bib66","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.trecan.2023.07.011","article-title":"Genitourinary cancer neoadjuvant therapies: current and future approaches","volume":"9","author":"Nair","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib67","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1602","article-title":"A spatially and temporally restricted mouse model of soft tissue sarcoma","volume":"13","author":"Kirsch","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib69","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8+ T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.05.001_bib70","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.celrep.2018.05.050","article-title":"Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity","volume":"23","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2025.05.001_bib71","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity","volume":"56","author":"M.A. Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.05.001_bib72","article-title":"Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer","volume":"9","author":"Hos","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.immuni.2025.05.001_bib73","first-page":"64","article-title":"IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8\u03b1+ Dendritic Cells Promotes Listeria monocytogenes","volume":"51","author":"Liu","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2025.05.001_bib74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.immuni.2011.06.012","article-title":"CD8\u03b1(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes","volume":"35","author":"Edelson","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.05.001_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.05.001_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc1600","article-title":"Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice","volume":"14","author":"Selvanesan","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib77","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-21-3226","article-title":"IFN\u03b3 Signaling in Natural and Therapy-Induced Antitumor Responses","volume":"28","author":"Mart\u00ednez-Sabadell","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib78","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.1700643","article-title":"PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination","volume":"199","author":"Memarnejadian","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003351","article-title":"Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants","volume":"9","author":"Conde","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib80","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical Role for CD103(+)\/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib81","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.05.001_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575967","article-title":"Mucosal CD8 T Cell Responses Are Shaped by Batf3-DC After Foodborne Listeria monocytogenes Infection","volume":"11","author":"Imperato","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib83","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nmeth762","article-title":"A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration","volume":"2","author":"Buch","year":"2005","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2025.05.001_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006692","article-title":"Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha","volume":"4","author":"Leschner","year":"2009","journal-title":"PLOS One"},{"key":"10.1016\/j.immuni.2025.05.001_bib85","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mt.2009.295","article-title":"Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy","volume":"18","author":"Jiang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.immuni.2025.05.001_bib86","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0406242101","article-title":"Bacteriolytic therapy can generate a potent immune response against experimental tumors","volume":"101","author":"Agrawal","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib87","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/mt.2014.36","article-title":"Bacterial Delivery of Staphylococcus aureus \u03b1-Hemolysin Causes Regression and Necrosis in Murine Tumors","volume":"22","author":"St Jean","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.immuni.2025.05.001_bib88","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.05.001_bib89","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202719119","article-title":"Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth","volume":"119","author":"Ahmed","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib90","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1462-5822.2008.01122.x","article-title":"Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment","volume":"10","author":"Weibel","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.immuni.2025.05.001_bib91","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1073\/pnas.1211287110","article-title":"Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer","volume":"110","author":"Quispe-Tintaya","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.05.001_bib92","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4161\/cbt.4.8.1891","article-title":"Enhanced therapeutic effect by combination of tumor-targeting salmonella and endostatin in murine melanoma model","volume":"4","author":"Jia","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.immuni.2025.05.001_bib93","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-07-2984","article-title":"Containment of tumor-colonizing bacteria by host neutrophils","volume":"68","author":"Westphal","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.immuni.2018.05.009","article-title":"Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses","volume":"49","author":"Kim","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.05.001_bib95","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1084\/jem.180.6.2209","article-title":"Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes","volume":"180","author":"Ikonomidis","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib96","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Biot","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2025.05.001_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.5MIR0917-351R","article-title":"IFN-\u03b3 orchestrates tumor elimination, tumor dormancy, tumor escape, and progression","author":"Aqbi","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.immuni.2025.05.001_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn9879","article-title":"Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanisms","volume":"9","author":"Li","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.05.001_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1158\/2326-6066.CIR-19-0251","article-title":"Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen Spreading","volume":"8","author":"Xin","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.05.001_bib102","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-024-00760-x","article-title":"An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy","volume":"5","author":"Chen","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2025.05.001_bib103","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41587-023-01957-8","article-title":"Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses","volume":"42","author":"Wang","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2025.05.001_bib104","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.immuni.2025.05.001_bib105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.immuni.2025.05.001_bib106","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/IAI.01088-06","article-title":"Cytosolic entry controls CD8+-T-cell potency during bacterial infection","volume":"74","author":"Bahjat","year":"2006","journal-title":"Infect. Immun."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325001943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325001943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:27:51Z","timestamp":1778797671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761325001943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":107,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1074761325001943"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2025.05.001","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}